최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Yonsei medical journal, v.58 no.1, 2017년, pp.19 - 26
Park, Hyung Seok (Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.) , Han, Hyun Ju (Avison Biomedical Research Center, Yonsei University College of Medicine, Seoul, Korea.) , Lee, Soohyeon (Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) , Kim, Gun Min (Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) , Park, Seho (Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.) , Choi, Yeon A (Avison Biomedical Research Center, Yonsei University College of Medicine, Seoul, Korea.) , Lee, Jeong Dong (Avison Biomedical Research Center, Yonsei University College of Medicine, Seoul, Korea.) , Kim, Gi Moon (Avison Biomedical Research Center, Yonsei University College of Medicine, Seoul, Korea.) , Sohn, Joohyuk (Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.) , Kim, Seung Il (Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.)
PurposeThe roles of circulating tumor cells (CTCs) as predictive and prognostic factors, as well as key mediators in the metastatic cascade, have been investigated. This study aimed to validate a method to quantify CTCs in peripheral blood using a real-time reverse transcriptase polymerase chain rea...
1 Fehm T Müller V Alix-Panabières C Pantel K Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance Breast Cancer Res 2008 10 Suppl 1 S1
2 Cristofanilli M Budd GT Ellis MJ Stopeck A Matera J Miller MC Circulating tumor cells, disease progression, and survival in metastatic breast cancer N Engl J Med 2004 351 781 791 15317891
3 Xenidis N Ignatiadis M Apostolaki S Perraki M Kalbakis K Agelaki S Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer J Clin Oncol 2009 27 2177 2184 19332733
4 Cristofanilli M Hayes DF Budd GT Ellis MJ Stopeck A Reuben JM Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 2005 23 1420 1430 15735118
5 Dawood S Broglio K Valero V Reuben J Handy B Islam R Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer 2008 113 2422 2430 18785255
6 Pantel K Alix-Panabières C Riethdorf S Cancer micrometastases Nat Rev Clin Oncol 2009 6 339 351 19399023
7 Paterlini-Brechot P Benali NL Circulating tumor cells (CTC) detection: clinical impact and future directions Cancer Lett 2007 253 180 204 17314005
8 Stathopoulou A Gizi A Perraki M Apostolaki S Malamos N Mavroudis D Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system Clin Cancer Res 2003 9 5145 5151 14613993
9 Ring AE Zabaglo L Ormerod MG Smith IE Dowsett M Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques Br J Cancer 2005 92 906 912 15714202
10 Van der Auwera I Peeters D Benoy IH Elst HJ Van Laere SJ Prové A Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer Br J Cancer 2010 102 276 284 19953098
11 Zhao S Liu Y Zhang Q Li H Zhang M Ma W The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a meta-analysis of published literature Breast Cancer Res Treat 2011 130 809 816 21311967
12 Stathopoulou A Ntoulia M Perraki M Apostolaki S Mavroudis D Malamos N A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer Int J Cancer 2006 119 1654 1659 16708381
13 Kahn HJ Yang LY Blondal J Lickley L Holloway C Hanna W RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters Breast Cancer Res Treat 2000 60 143 151 10845277
14 Stathopoulou A Vlachonikolis I Mavroudis D Perraki M Kouroussis Ch Apostolaki S Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance J Clin Oncol 2002 20 3404 3412 12177100
15 Xenidis N Vlachonikolis I Mavroudis D Perraki M Stathopoulou A Malamos N Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer Ann Oncol 2003 14 849 855 12796021
16 Xenidis N Perraki M Kafousi M Apostolaki S Bolonaki I Stathopoulou A Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients J Clin Oncol 2006 24 3756 3762 16769987
17 Xenidis N Markos V Apostolaki S Perraki M Pallis A Sfakiotaki G Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer Ann Oncol 2007 18 1623 1631 17515404
18 Ignatiadis M Perraki M Apostolaki S Politaki E Xenidis N Kafousi M Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer Clin Breast Cancer 2007 7 883 889 18269779
19 Ignatiadis M Xenidis N Perraki M Apostolaki S Politaki E Kafousi M Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer J Clin Oncol 2007 25 5194 5202 17954712
20 Ignatiadis M Kallergi G Ntoulia M Perraki M Apostolaki S Kafousi M Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer Clin Cancer Res 2008 14 2593 2600 18451221
21 Chen Y Zou TN Wu ZP Zhou YC Gu YL Liu X Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer Int J Biol Markers 2010 25 59 68 20586026
22 Benoy IH Elst H Philips M Wuyts H Van Dam P Scharpé S Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer Br J Cancer 2006 94 672 680 16495933
23 Daskalaki A Agelaki S Perraki M Apostolaki S Xenidis N Stathopoulos E Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer Br J Cancer 2009 101 589 597 19623181
24 Grünewald K Haun M Urbanek M Fiegl M Müller-Holzner E Gunsilius E Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19 Lab Invest 2000 80 1071 1077 10908152
25 Cha YJ Jung WH Cho NH Koo JS Expression of sarcosine metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma Yonsei Med J 2015 56 598 607 25837163
26 Criscitiello C Sotiriou C Ignatiadis M Circulating tumor cells and emerging blood biomarkers in breast cancer Curr Opin Oncol 2010 22 552 558 20706122
27 Thurm H Ebel S Kentenich C Hemsen A Riethdorf S Coith C Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy Clin Cancer Res 2003 9 2598 2604 12855636
28 Rack B Schindlbeck C Jückstock J Andergassen U Hepp P Zwingers T Circulating tumor cells predict survival in early average-to-high risk breast cancer patients J Natl Cancer Inst 2014 5 15 [Epub] 10.1093/jnci/dju066
29 Soltani S Mokarian F Panjehpour M The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women Res Pharm Sci 2015 10 485 496 26779268
30 Hayes DF Cristofanilli M Budd GT Ellis MJ Stopeck A Miller MC Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival Clin Cancer Res 2006 12 14 Pt 1 4218 4224 16857794
31 de Bono JS Scher HI Montgomery RB Parker C Miller MC Tissing H Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer Clin Cancer Res 2008 14 6302 6309 18829513
32 Tewes M Aktas B Welt A Mueller S Hauch S Kimmig R Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies Breast Cancer Res Treat 2009 115 581 590 18679793
33 Hyun KA Koo GB Han H Sohn J Choi W Kim SI Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer Oncotarget 2016 7 24677 24687 27013581
34 Lohr JG Adalsteinsson VA Cibulskis K Choudhury AD Rosenberg M Cruz-Gordillo P Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer Nat Biotechnol 2014 32 479 484 24752078
35 Aceto N Bardia A Miyamoto DT Donaldson MC Wittner BS Spencer JA Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis Cell 2014 158 1110 1122 25171411
36 Yu M Bardia A Aceto N Bersani F Madden MW Donaldson MC Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility Science 2014 345 216 220 25013076
37 Hyun KA Kwon K Han H Kim SI Jung HI Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients Biosens Bioelectron 2013 40 206 212 22857995
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.